{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:36:52Z","timestamp":1774615012096,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"abstract":"<jats:p>\n                    DA-9601 extracted from\n                    <jats:italic toggle=\"yes\">Artemisia asiatica<\/jats:italic>\n                    contains a bioactive compound \u2013 eupatilin \u2013 that can protect against gastric mucosal damage through anti-inflammatory and anti-oxidative properties and is approved for treating acute and chronic gastritis in Korea, but their ability to protect gastrointestinal (GI) bleeding caused by nonsteroidal anti-inflammatory drugs (NSAIDs) is unclear. We aimed to compare the protective effects of DA-9601 to those of proton pump inhibitors (PPI) and rebamipide against upper and lower GI bleeding in patients with rheumatoid arthritis (RA) undergoing long-term NSAIDs therapy using the Korean Health Insurance Review and Assessment database. In this nationwide retrospective cohort study, we evaluated patients with RA who concurrently received NSAIDs for &gt;3 months with DA-9601, PPI, or rebamipide between January 2015 and December 2017. The index date was the date of NSAIDs initiation, and all patients were followed up until December 2020 to detect upper and lower GI bleeding. In total, 24,258 patients with RA were eligible, and 5468 (22.5%), 4417 (18.2%), and 14,373 (59.3%) received DA-9601, PPI, or rebamipide, respectively, on the index date. During follow-up, upper and lower GI bleeding occurred in 508 (2.1%) and 402 (1.6%) patients with RA, respectively. The incidence rate of upper and lower GI bleeding was 615\/100,000 and 485\/100,000 person-years, respectively. Among patients with RA receiving DA-9601, PPI, or rebamipide, the frequencies of NSAIDs-induced upper GI bleeding were 0.5%, 0.4%, and 1.2%, respectively. The frequencies of NSAIDs-induced lower GI bleeding were 0.4%, 0.4%, and 0.9%, respectively. The incidence of NSAIDs-induced upper GI bleeding in patients with RA receiving DA-9601, PPI, and rebamipide was 601\/100,000, 705\/100,000, and 596\/100,000 person-years, respectively, while the incidence of NSAIDs-induced lower GI bleeding in the same groups was 449\/100,000, 608\/100,000, and 465\/100,000 person-years, respectively. In the multivariate Cox regression analysis, no significant difference was observed in lower and upper GI bleeding hazards between patients with RA using DA-9601, PPI, and rebamipide. Our results suggest that DA-9601 may exhibit protection against NSAIDs-induced GI bleeding that is comparable to those of PPI and rebamipide in patients with RA.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000038801","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T16:04:42Z","timestamp":1720195482000},"page":"e38801","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["DA-9601 has protective effects comparable to those of proton pump inhibitor and rebamipide against nonsteroidal anti-inflammatory drugs-induced upper and lower gastrointestinal bleeding in patients with rheumatoid arthritis: A nationwide study using Korean Health Insurance Review and Assessment Service database"],"prefix":"10.1097","volume":"103","author":[{"given":"Min Wook","family":"So","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea"},{"name":"Division of Rheumatology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aran","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea"},{"name":"Division of Rheumatology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea"},{"name":"Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Geun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea"},{"name":"Division of Rheumatology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea"},{"name":"Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4078\/jrd.2023.0006","article-title":"The relationship between long-term use of nonsteroidal anti-inflammatory drugs and kidney function in patients with ankylosing spondylitis.","volume":"30","author":"Koo","year":"2023","journal-title":"J Rheum Dis"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.3748\/wjg.v17.i42.4647","article-title":"Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.","volume":"17","author":"Park","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/gast.2002.33647","article-title":"COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.","volume":"122","author":"Sigthorsson","year":"2002","journal-title":"Gastroenterology"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5217\/ir.2017.15.4.446","article-title":"Non-steroidal anti-inflammatory drug-induced enteropathy.","volume":"15","author":"Shin","year":"2017","journal-title":"Intest Res"},{"issue":"Suppl 3","key":"R5-20260109","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar4175","article-title":"Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.","volume":"15","author":"Sostres","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"707","DOI":"10.5009\/gnl20246","article-title":"Clinical guidelines for drug-related peptic ulcer, 2020 Revised Edition.","volume":"14","author":"Joo","year":"2020","journal-title":"Gut Liver"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"e00588","DOI":"10.14309\/ctg.0000000000000588","article-title":"Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-related small-bowel injury: a systematic review with meta-analysis.","volume":"14","author":"Zhang","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/JPR.S156938","article-title":"Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.","volume":"11","author":"Gwee","year":"2018","journal-title":"J Pain Res"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3904\/kjim.2021.216","article-title":"The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study.","volume":"37","author":"Oh","year":"2022","journal-title":"Korean J Intern Med"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1440-1746.2008.05333.x","article-title":"Artemisia asiatica extracts protect against ethanol-induced injury in gastric mucosa of rats.","volume":"23","author":"Park","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4196\/kjpp.2021.25.5.439","article-title":"Anti-inflammatory effects of DA-9601, an extract of Artemisia asiatica, on aceclofenac-induced acute enteritis.","volume":"25","author":"Kim","year":"2021","journal-title":"Korean J Physiol Pharmacol"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4093\/dmj.2020.0207","article-title":"Data configuration and publication trends for the Korean National health insurance and health insurance review & assessment database.","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00296-012-2590-2","article-title":"Prevalence and incidence of rheumatoid arthritis in South Korea.","volume":"33","author":"Sung","year":"2013","journal-title":"Rheumatol Int"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apt.12483","article-title":"Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.","volume":"38","author":"Lin","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00198-014-2647-z","article-title":"Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study.","volume":"25","author":"Peng","year":"2014","journal-title":"Osteoporos Int"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3346\/jkms.2011.26.8.1074","article-title":"Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.","volume":"26","author":"Lee","year":"2011","journal-title":"J Korean Med Sci"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s12272-014-0408-3","article-title":"A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment.","volume":"37","author":"Lee","year":"2014","journal-title":"Arch Pharm Res"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3904\/kjim.2022.340","article-title":"Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users.","volume":"38","author":"Lee","year":"2023","journal-title":"Korean J Intern Med"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.89.1","article-title":"Alteration of gastric ulcerogenic and healing responses in rats with adjuvant-induced arthritis.","volume":"89","author":"Kato","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0016-5085(95)90576-6","article-title":"Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats.","volume":"109","author":"McCafferty","year":"1995","journal-title":"Gastroenterology"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"e0190798","DOI":"10.1371\/journal.pone.0190798","article-title":"Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: a meta-analysis.","volume":"13","author":"Feng","year":"2018","journal-title":"PLoS One"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1038\/s41598-019-48173-6","article-title":"Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users.","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/rheumatology\/ken193","article-title":"Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population.","volume":"47","author":"Grijalva","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"e0248866","DOI":"10.1371\/journal.pone.0248866","article-title":"Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: systematic review and network meta-analysis.","volume":"16","author":"Paglia","year":"2021","journal-title":"PLoS One"},{"key":"R25-20260109","doi-asserted-by":"crossref","first-page":"818877","DOI":"10.3389\/fphar.2022.818877","article-title":"NSAID-associated small intestinal injury: an overview from animal model development to pathogenesis, treatment, and prevention.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ueg2.12448","article-title":"Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: a systematic review and meta-analysis.","volume":"11","author":"Jung","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3748\/wjg.v10.i16.2379","article-title":"DA-9601 for erosive gastritis: results of a double-blind placebo-controlled phase III clinical trial.","volume":"10","author":"Seol","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R28-20260109","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3346\/jkms.2017.32.11.1807","article-title":"Evaluation of the efficacy and safety of DA-9601 versus Its New Formulation, DA-5204, in patients with gastritis: phase III, randomized, double-blind, non-inferiority study.","volume":"32","author":"Choi","year":"2017","journal-title":"J Korean Med Sci"},{"key":"R29-20260109","doi-asserted-by":"crossref","first-page":"268382","DOI":"10.1155\/2013\/268382","article-title":"NSAID-induced enteropathy in rheumatoid arthritis patients with chronic occult gastrointestinal bleeding: a prospective capsule endoscopy study.","volume":"2013","author":"Tacheci","year":"2013","journal-title":"Gastroenterol Res Pract"},{"key":"R30-20260109","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2013-304713","article-title":"Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients.","volume":"63","author":"Watanabe","year":"2014","journal-title":"Gut"},{"key":"R31-20260109","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/gast.2003.50054","article-title":"Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.","volume":"124","author":"Laine","year":"2003","journal-title":"Gastroenterology"},{"key":"R32-20260109","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants a nationwide propensity score-weighted study.","volume":"174","author":"Ingason","year":"2021","journal-title":"Ann Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:04:18Z","timestamp":1767967458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":32,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038801","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}